NEW YORK, September 24, 2018 /PRNewswire/ --
According to a report from New Frontier Data, the U.S. legal cannabis market is expected to grow at a compound annual growth rate (CAGR) of 14.7% to USD 25 Billion by 2025. The market can be segmented into medical cannabis and recreational cannabis. Demand for medical cannabis continues to increase. The report projects that the medical market is set to grow from USD 5.1 Billion in 2017 to USD 12.5 Billion by 2025, with a GAGR of 11.8%, while the recreational market is projected to grow at a faster rate of 18.4% during the forecast periods. The recreational market is expected to have a value of USD 12.5 Billion by 2025. AmeriCann, Inc. (OTC: ACAN), Innovative Industrial Properties, Inc. (NYSE: IIPR), Kush Bottles Inc. (OTC: KSHB), Cannabis Sativa, Inc. (OTC: CBDS), GW Pharmaceuticals plc (NASDAQ: GWPH)
Giadha Aguirre De Carcer, New Frontier Data CEO and Founder explained: "Across the globe, we have seen massive expansion as more than 50 countries are legalizing or decriminalizing cannabis. However, the United States continues to lead the way in cannabis consumption in legal medical and adult use markets. With a number of states expected to advance cannabis legalization measures in the next 24 months, more Americans will be able to access legal cannabis in the years to come, making this a watershed 4/20."
AmeriCann, Inc. (OTCQB: ACAN) recently announced breaking cannabis news that this week, "AmeriCann to Host Ground Breaking Celebration for the Massachusetts Medical Cannabis Center on Tuesday, September 25, an agricultural-technology company that is developing the next generation of eco-friendly start-of-the-art greenhouse cannabis cultivation and processing properties, plans to host a ground breaking celebration for its Massachusetts Medical Cannabis Center (MMCC) on Tuesday, September 25.
AmeriCann designed the MMCC on a 52-acre parcel located in Freetown, Mass. The project allows for 987,000 sq. ft. of cannabis cultivation and processing infrastructure and will be developed in three phases. The ground breaking event will celebrate the first phase of the MMCC construction which will be a 30,000 sq. ft. cannabis cultivation, processing and research facility. AmeriCann plans to complete the first phase of the MMCC by the spring of 2019. Campanelli Construction is the general contractor and CBRE/New England is the project manager for the MMCC. The first phase of the MMCC project consists of 30,000 sq. ft. of cultivation, processing and research facilities.
"We believe the first of phase will set new standards for the industry and have a big impact for the company moving forward," stated AmeriCann Founder Ben Barton. "The ground breaking signifies the first step in creating a sustainable process to produce clean, quality cannabis."
AmeriCann uses greenhouse technology, which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25 percent fewer light bulbs, and utility bills are up to 75 percent less than in typical warehouse cultivation facilities. As such, AmeriCann's Cannopy System enables cannabis to be produced with a greatly reduced carbon footprint, making the final product less expensive. Additionally, greenhouse construction costs are nearly half of warehouse construction costs.
The MMCC will be built to maximize workflow and take advantage of growing plants under natural sunlight which the Company believes produces healthier plants from both cannabinoid and terpene perspectives, making the final product higher in quality.
"Currently, almost all the cannabis being produced in Massachusetts is from converted warehouses with 100 percent artificial light, high energy costs and huge carbon footprints," said Tim Keogh, AmeriCann's Chief Executive Officer. "The MMCC facility is designed to produce superior sun grown cannabis products year-round in a controlled environment at a lower cost. This is the first phase of an extensive project designed to help the Massachusetts cannabis industry reach its full potential."
AmeriCann assists partners to obtain licenses and cultivate medicine in its next generation of eco-friendly state-of-the-art cannabis cultivation facilities and provides essential resources including access to a team of experts, and capital, which has been traditionally hard to obtain for cannabis companies. The first publicly traded Certified B Corp in the cannabis industry, AmeriCann has proven its commitment to sustainable, clean cultivation of medical cannabis.
About Massachusetts Medical Cannabis Center - In 2015, AmeriCann realized that Massachusetts did not have adequate cultivation and processing infrastructure in planning or development. With that knowledge, AmeriCann designed the MMCC on a 52-acre parcel of land by securing site plan approval and all the entitlements for 987,000 square feet of cannabis cultivation and processing infrastructure. The MMCC project will be developed in phases and is expected to be one of the most technologically advanced cultivation facilities in the nation. The state-of-the-art, sustainable greenhouse project will consist of multiple planned phases for multiple tenants in the Massachusetts cannabis industry. Voters in Massachusetts approved legalizing the adult use of recreational marijuana in November of 2016 making Massachusetts the first state in the Northeast to legalize adult-use cannabis.
AmeriCann'sCannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures. The Company is planning to replicate the Cannopy platform in additional states.
About AmeriCann is a publicly traded agricultural technology (Ag-Tech) company that is developing a new generation of sustainable, state-of-the-art medical cannabis cultivation and processing properties. AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the Company's commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: http://www.americann.co "
Innovative Industrial Properties, Inc. (NYSE: IIPR) is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Earlier in August, the Company announced that it closed on the acquisition of the property located at 10070 Harvest Park in Dimondale, Michigan, which is currently under development and expected to comprise approximately 56,000 sq. ft. upon completion. Concurrent with the closing of the purchase, the Company entered into a long-term, triple-net lease agreement with Green Peak, which intends to utilize the facility for medical cannabis cultivation and processing upon completion of development. The initial term of the lease is 15 years, with two options to extend the term for two additional five-year periods.
Kush Bottles Inc. (OTCQB: KSHB) is a dynamic sales platform that provides unique products and services for both businesses and consumers in the cannabis industry including CBD manufacturers. Recently, the Company announced that it has launched Kush Energy, a new division focused on supplying the cannabis industry with tested, high-quality solvents and hydrocarbons, which are essential in the extraction process for the production of products including oils, edibles and waxes. The Company acquired Summit Innovations in May of 2018, and now, with the launch of Kush Energy, has successfully completed a full integration. Kush Energy will focus on servicing the rapidly growing concentrates category, which in many primary cannabis markets now account for nearly half of all sales. Kush Energy will operate eight hazmat compliant distribution facilities across the country, including a new location in Humboldt County in Northern California. The new division will also work closely with cannabis manufacturers and extraction facilities to ensure cleanliness, product quality, reliable supply, safety, and compliance during the extraction process.
Cannabis Sativa, Inc. (OTCQB: CBDS) announced on April 5th that PrestoDoctor®, the leading online medical marijuana recommendation service, expanded to Pennsylvania on April 20th, 2018. CBDS licenses the "hi" and "White Rabbit" brands, holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, owns patent pending and trade secret formulas and processes, offers the hi benefits discount pharmacy card, and operates subsidiaries that include: PrestoDoctor®. "We are extremely excited to be expanding to Pennsylvania, and to help patients have easier access in obtaining a medical marijuana card," said PrestoDoctor® Co-Founder and CEO, Kyle Powers. "With so many people looking for an opioid alternative, and other natural options, it's important to provide an easy, honest, and affordable service," he added.
GW Pharmaceuticals plc (NASDAQ: GWPH) is the world leader in the development and commercialization of cannabinoid prescription medicines. The Company's lead product, EPIDIOLEX® (cannabidiol) oral solution, received U.S. FDA approval in June 2018 and is under review by European regulators. Last month, the Company announced financial results for the third quarter ended June 30th, 2018. Revenue for the nine months ended June 30th, 2018 was GBP 10.7 Million (USD 14.2 Million) compared to GBP 6.1 Million for the nine months ended June 30th, 2018. During the quarter, the Company expanded access program and open label extension over 2,000 patients now have been exposed to Epidiolex treatment life-cycle management.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information: